Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 14:10:1087702.
doi: 10.3389/fcvm.2023.1087702. eCollection 2023.

Prediction of in-hospital adverse clinical outcomes in patients with pulmonary thromboembolism, machine learning based models

Affiliations

Prediction of in-hospital adverse clinical outcomes in patients with pulmonary thromboembolism, machine learning based models

Yaser Jenab et al. Front Cardiovasc Med. .

Abstract

Background: Pulmonary thromboembolism (PE) is the third leading cause of cardiovascular events. The conventional modeling methods and severity risk scores lack multiple laboratories, paraclinical and imaging data. Data science and machine learning (ML) based prediction models may help better predict outcomes.

Materials and methods: In this retrospective registry-based design, all consecutive hospitalized patients diagnosed with pulmonary thromboembolism (based on pulmonary CT angiography) from 2011 to 2019 were recruited. ML based algorithms [Gradient Boosting (GB) and Deep Learning (DL)] were applied and compared with logistic regression (LR) to predict hemodynamic instability and/or all-cause mortality.

Results: A total number of 1,017 patients were finally enrolled in the study, including 465 women and 552 men. Overall incidence of study main endpoint was 9.6%, (7.2% in men and 12.4% in women; p-value = 0.05). The overall performance of the GB model is better than the other two models (AUC: 0.94 for GB vs. 0.88 and 0.90 for DL and LR models respectively). Based on GB model, lower O2 saturation and right ventricle dilation and dysfunction were among the strongest adverse event predictors.

Conclusion: ML-based models have notable prediction ability in PE patients. These algorithms may help physicians to detect high-risk patients earlier and take appropriate preventive measures.

Keywords: gradient boosting machine; logistic models; machine learing; outcome analysis; pulmonary embolism; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of the receiver operating characteristic curve (ROC curve) of machine learning models. AUC, area under the curve.
Figure 2
Figure 2
Comparison of the precision-recall curve (PR curve) of machine learning models. AUC, area under the curve.
Figure 3
Figure 3
SHAP summary plot sorts the features used in the gradient boosting model, concerning their importance in the final decision-making process. The y-axis shows the variables, while the x-axis represents the Shapley value of each variable. The colors illustrate the relationship between features and prediction (composite adverse outcomes), red shows the direct relationship, whereas blue means inverse relation. SHAP, SHapley Additive exPlanations; Echo, echocardiography; Lab, laboratory test; CT angio, pulmonary CT angiography.
Figure 4
Figure 4
Graph of classification-error of the gradient boosting model versus the number of trees, showing the decreasing trend of errors in both training and validation datasets.

Similar articles

Cited by

References

    1. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. (2012) 379(9828):1835–46. 10.1016/s0140-6736(11)61904-1 - DOI - PubMed
    1. Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet. (2016) 388(10063):3060–73. 10.1016/s0140-6736(16)30514-1 - DOI - PubMed
    1. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. (2007) 44(2):62–9. 10.1053/j.seminhematol.2007.02.004 - DOI - PMC - PubMed
    1. Secemsky E, Chang Y, Jain CC, Beckman JA, Giri J, Jaff MR, et al. Contemporary management and outcomes of patients with massive and submassive pulmonary embolism. Am J Med. (2018) 131(12):1506–14.e0. 10.1016/j.amjmed.2018.07.035 - DOI - PubMed
    1. van Beek EJ, Kuijer PM, Büller HR, Brandjes DP, Bossuyt PM, ten Cate JW. The clinical course of patients with suspected pulmonary embolism. Arch Intern Med. (1997) 157(22):2593–8. 10.1001/archinte.157.22.2593 - DOI - PubMed

LinkOut - more resources